title: Association analysis of the ephrin-B2 gene in African-Americans with end-stage renal disease.
abstract: BACKGROUND
  Genome scans in African-Americans with end-stage renal disease (ESRD) identified linkage on chromosome 13q33 in the region containing the ephrin-B2 ligand (EFNB2) genes. Interactions between the ephrin-B2 receptor and ephrin-B2 ligand play essential roles in renal angiogenesis, blood vessel maturation, and kidney disease.
  
  
  METHODS
  The EFNB2 gene was evaluated as a positional candidate for non-diabetic and diabetic ESRD susceptibility in 1,071 unrelated African-American subjects; 316 with non-diabetic etiologies of ESRD, 394 with type 2 diabetes-associated ESRD and 361 healthy controls. Single nucleotide polymorphism (SNP) genotyping was performed on the Sequenom Mass Array System. Statistical analyses were computed using Dandelion version 1.26, Snpaddmix version 1.4 and Haploview version 3.32.
  
  
  RESULTS
  Twenty-eight HapMap tag SNPs were genotyped spanning the 39 kilobases (kb) of the EFNB2 coding region, with average spacing of 1.43 kb. Analysis of 710 ESRD patient samples and 361 controls provided no evidence of single SNP associations in either diabetic or non-diabetic ESRD; although nominal evidence of association with all-cause ESRD was observed with a two SNP (p = 0.022) and three SNP (p = 0.023) haplotype, both containing SNPs rs7490924 and rs2391335 in intron 1.
  
  
  CONCLUSIONS
  Although an attractive positional candidate gene, polymorphisms in the EFNB2 gene do not appear to contribute in a substantial way to non-diabetic, diabetic or all-cause ESRD susceptibility in African-Americans. Additional genes within the chromosome 13q33 linkage interval are likely contributors to African-American non-diabetic ESRD.
authors.affiliation: Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1053, USA.
authors.forename: Pamela J
authors.initials: PJ
authors.lastname: Hicks
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Staten
authors.forename: Nicholette D
authors.initials: ND
authors.lastname: Palmer
authors.forename: Carl D
authors.initials: CD
authors.lastname: Langefeld
authors.forename: Julie T
authors.initials: JT
authors.lastname: Ziegler
authors.forename: Keith L
authors.initials: KL
authors.lastname: Keene
authors.forename: Michele M
authors.initials: MM
authors.lastname: Sale
authors.forename: Donald W
authors.initials: DW
authors.lastname: Bowden
authors.forename: Barry I
authors.initials: BI
authors.lastname: Freedman
mesh_terms: D000328:Adult; D001741:Black or African American; D000368:Aged; D000483:Alleles; D036388:Ephrin-B2 / Q000097:blood / Q000235:genetics* / Q000502:physiology*; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D007438:Introns; D007676:Kidney Failure, Chronic / Q000097:blood / Q000208:ethnology* / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic; D020641:Polymorphism, Single Nucleotide
chemical_list: D036388:Ephrin-B2